Managing bronchiolitis in pediatric patients: Current evidence
Background: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent...
Main Authors: | Subhranshu Sekhar Dhal, Hiremath Sagar |
---|---|
Format: | Article |
Language: | English |
Published: |
Jaypee Brothers Medical Publisher
2022-01-01
|
Series: | Indian Journal of Respiratory Care |
Subjects: | |
Online Access: | http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhal |
Similar Items
-
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
by: Gaëlle Beal, et al.
Published: (2019-11-01) -
Comparison of nebulized 3% hypertonic saline with 0.9% normal saline for treatment of acute bronchiolitis in children up to 2 years of age
by: Somayya Siddiqa, et al.
Published: (2019-09-01) -
Current management of acute bronchiolitis in Switzerland
by: Swiss Medical Weekly
Published: (2003-01-01) -
Efficacy of Nebulized Hypertonic Saline 3% in comparison to Nebulized Normal Saline 0.9% in Children with Acute Bronchiolitis
by: Hosam Elesh, et al.
Published: (2021-07-01) -
The Effect of Hypertonic Saline in Treatment of Moderate Bronchiolitis in Children
by: Alaa Nasrawi
Published: (2021-12-01)